Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Healeon HD-PRP
- Development stage
- Unknown
- Lead developer
- Bimini Health Tech
- Modality
- Cell Therapies
- Administration
- Intraarticular
01
Overview
Healeon HD-PRP is an autologous platelet-rich plasma (PRP) concentrate developed by Healeon Medical for the treatment of osteoarthritis and associated connective tissue degeneration. It is prepared from the patient's own peripheral blood using the Terumo-Harvest System, which concentrates platelets to levels significantly higher than baseline. Upon activation, these platelets release a variety of growth factors, including platelet-derived growth factor (PDGF), transforming growth factor-beta (TGF-β), and vascular endothelial growth factor (VEGF). These factors work synergistically to promote tissue repair, stimulate angiogenesis, and modulate the inflammatory environment within the joint. In clinical practice, Healeon HD-PRP is frequently utilized as a component of biocellular regenerative therapy, often combined with adipose-derived stromal vascular fraction (SVF) to enhance therapeutic outcomes.
- Brand names
- Healeon HD-PRP
- Other names
- Platelet-Rich PlasmaPRP Concentrateautologous platelet-rich plasma
Beyond the preview
Go deeper on Healeon HD-PRP.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Healeon HD-PRP.